Live Price
Live Volume
REGENXBIO Market Segments
Overnight
*No Trades in Segment
After Hours
*No Trades in Segment
Regular Trading Hours
*No Trades in Segment
Premarket
*No Trades in Segment
After Hours Yesterday
| Open | $6.60 |
|---|---|
| Close | $6.70 |
| Low | $6.49 |
| Low Change | -0.11 (-1.67%) |
| High | $6.78 |
| High Change | +0.18 (+2.73%) |
| Range | $0.29 |
| Volume | 235.557K |
| Dollar Volume | $1.58M |
Regular Trading Hours Yesterday
| Open | $6.54 |
|---|---|
| Close | $6.59 |
| Low | $6.46 |
| Low Change | -0.08 (-1.24%) |
| High | $6.78 |
| High Change | +0.24 (+3.67%) |
| Range | $0.32 |
| Volume | 963.19K |
| Dollar Volume | $6.35M |
Premarket Yesterday
| Open | $6.53 |
|---|---|
| Close | $6.55 |
| Low | $6.53 |
| Low Change | 0.00 (0.00%) |
| High | $6.55 |
| High Change | +0.02 (+0.26%) |
| Range | $0.02 |
| Volume | 700 |
| Dollar Volume | $4.59K |
REGENXBIO News
1 month agoinvesting.comWhy is Regenxbio stock climbing today?
- 1 month agoinvesting.com
Regenxbio stock gains on positive gene therapy trial data
- 2 months agoinvesting.com
Regenxbio stock surges on director share purchases
- 2 months agoinvesting.com
Why is Regenxbio stock plunging today?
- 2 months agoinvesting.com
REGENXBIO stock tumbles after FDA clinical hold on MPS II therapy
2 months agobarrons.comWhy Regenxbio Halted Its Gene Therapy Trial—and Why the Stock Is Tumbling
- 3 months agoinvesting.com
Why is Regenxbio stock falling sharply today?
- 3 months agoinvesting.com
Why is Regenxbio stock sliding today?
- 3 months agoinvesting.com
After-Hours Stock Movers: NFLX, ISRG, KO, AA, RGNX
- 3 months agoinvesting.com
REGENXBIO stock tumbles on $100M public offering plan
REGENXBIO Top Trades
We are still processing the top long and short trades for today. Please refresh the page in 10 minutes or sign up for Finsuba Premium for real time trade insights.
REGENXBIO Moving Averages
| 5 Day Moving Average (SMA5) | $6.84 |
|---|---|
| 10 Day Moving Average (SMA10) | $6.97 |
| 20 Day Moving Average (SMA20) | $7.30 |
| 50 Day Moving Average (SMA50) | $8.23 |
| 100 Day Moving Average (SMA100) | $9.29 |
| 200 Day Moving Average (SMA200) | $9.29 |
REGENXBIO Statistics
| Average Volume (30 Days) | 1.4M |
|---|---|
| P/E Ratio (Current) | -2.71 |
| EPS (Current) | -$2.98 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$249.67M |
| Cash Ratio | 0.44 |
| Current Ratio | 2.86 |
| Quick Ratio | 2.86 |
| Debt to Equity | 0.00 |
| Enterprise Value | $496.24M |
| EV to EBITDA | -3.34 |
| EV to Sales | 2.84 |
| Price to Book | 7.42 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | 3.05 |
| Return on Assets | -0.51% |
| Return on Equity | -2.74% |
REGENXBIO Stock Splits
There have been no stock splits for REGENXBIO (RGNX).
REGENXBIO Dividends
There have been no dividends for REGENXBIO (RGNX).